FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bruce Wolffenbuttel

Research Profile

Disorders

Chemicals & Drugs

Geographic Areas

Netherlands

Concepts & Ideas

Co-author Network

Publications

TOP 3
Pauline Brummelman; Martin F Elderson; Robin P F Dullaart; Alfons C M van den Bergh; Cees A Timmer; Gerrit van den Berg; Janneke Koerts; Oliver Tucha; Bruce Wolffenbuttel; André P van Beek
Cognitive functioning in patients treated for nonfunctioning pituitary macroadenoma and the effects of pituitary radiotherapy.
Marike C Schokker; Thera P Links; Jelte Bouma; Joost C Keers; Robbert Sanderman; Bruce Wolffenbuttel; Mariët Hagedoorn
The role of overprotection by the partner in coping with diabetes: a moderated mediation model.
Paul J W H Kappelle; Josefin Ahnström; Bert D Dikkeschei; Rindert de Vries; Wim J Sluiter; Bruce Wolffenbuttel; Arie Van Tol; Lars Bo Nielsen; Björn Dahlbäck; R P F Dullaart
Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bruce Wolffenbuttel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Pauline Brummelman; Martin F Elderson; Robin P F Dullaart; Alfons C M van den Bergh; Cees A Timmer; Gerrit van den Berg; Janneke Koerts; Oliver Tucha; Bruce Wolffenbuttel; André P van Beek
Cognitive functioning in patients treated for nonfunctioning pituitary macroadenoma and the effects of pituitary radiotherapy.
Clinical endocrinology 2011;74(4):481-7.
2011: Marike C Schokker; Thera P Links; Jelte Bouma; Joost C Keers; Robbert Sanderman; Bruce Wolffenbuttel; Mariët Hagedoorn
The role of overprotection by the partner in coping with diabetes: a moderated mediation model.
Psychology & health 2011;26(1):95-111.
2010: Paul J W H Kappelle; Josefin Ahnström; Bert D Dikkeschei; Rindert de Vries; Wim J Sluiter; Bruce Wolffenbuttel; Arie Van Tol; Lars Bo Nielsen; Björn Dahlbäck; R P F Dullaart
Plasma apolipoprotein M responses to statin and fibrate administration in type 2 diabetes mellitus.
Atherosclerosis 2010;213(1):247-50.
2010: Marike C Schokker; Ilse Stuive; Jelte Bouma; Joost C Keers; Thera P Links; Bruce Wolffenbuttel; Robbert Sanderman; Mariët Hagedoorn
Support behavior and relationship satisfaction in couples dealing with diabetes: main and moderating effects.
Journal of family psychology : JFP : journal of the Division of Family Psychology of the American Psychological Association (Division 43) 2010;24(5):578-86.
2010: Jaco Voorham; Floor M Haaijer-Ruskamp; Klaas van der Meer; Dick de Zeeuw; Bruce Wolffenbuttel; Klaas Hoogenberg; Petra Denig
Identifying targets to improve treatment in type 2 diabetes; the Groningen Initiative to aNalyse Type 2 diabetes Treatment (GIANTT) observational study.
Pharmacoepidemiology and drug safety 2010;19(10):1078-86.
2010: Voorham Jaco; Flora M Haaijer-Ruskamp; Bruce Wolffenbuttel; R P Stolk; Petra Denig
Cardiometabolic treatment decisions in patients with type 2 diabetes: the role of repeated measurements and medication burden.
Quality & safety in health care 2010;19(5):411-5.
2010: André P van Beek; Bruce Wolffenbuttel; Evelien Runge; Peter J Trainer; Peter J Jönsson; Maria Koltowska Häggström
The pituitary gland and age-dependent regulation of body composition.
The Journal of clinical endocrinology and metabolism 2010;95(8):3664-74.
2010: Marike C Schokker; Joost C Keers; Jelte Bouma; Thera P Links; Robbert Sanderman; Bruce Wolffenbuttel; Mariët Hagedoorn
The impact of social comparison information on motivation in patients with diabetes as a function of regulatory focus and self-efficacy.
Health psychology : official journal of the Division of Health Psychology, American Psychological Association 2010;29(4):438-45.
2010: Wilhelmina H A de Jong; Elisabeth G E de Vries; Bruce Wolffenbuttel; Ido P Kema
Automated mass spectrometric analysis of urinary free catecholamines using on-line solid phase extraction.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2010;878(19):1506-12.
2010: Walter K H Kuchenbecker; Henk Groen; Tineke M Zijlstra; Johanna H T Bolster; Riemer H J Slart; Erik J van der Jagt; Anneke C Muller Kobold; Bruce Wolffenbuttel; Jolande A Land; Annemieke Hoek
The subcutaneous abdominal fat and not the intraabdominal fat compartment is associated with anovulation in women with obesity and infertility.
The Journal of clinical endocrinology and metabolism 2010;95(5):2107-12.
2010: Liana Martirosyan; Voorham Jaco; Flora M Haaijer-Ruskamp; Jozé Braspenning; Bruce Wolffenbuttel; Petra Denig
A systematic literature review: prescribing indicators related to type 2 diabetes mellitus and cardiovascular risk management.
Pharmacoepidemiology and drug safety 2010;19(4):319-34.
2010: Esther C de Haas; Sjoukje F Oosting; Joop D Lefrandt; Bruce Wolffenbuttel; Dirk Th Sleijfer; Jourik A Gietema
The metabolic syndrome in cancer survivors.
The lancet oncology 2010;11(2):193-203.
2010: Pim van der Harst; Stephan J L Bakker; Rudolf A de Boer; Bruce Wolffenbuttel; Toby Johnson; Mark J Caulfield; gerjan navis
Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms.
Human molecular genetics 2010;19(2):387-95.
2010: Voorham Jaco; Flora M Haaijer-Ruskamp; Klaas van der Meer; Dick de Zeeuw; Bruce Wolffenbuttel; Klaas Hoogenberg; Petra Denig
[Quality of the treatment of type 2 diabetes: results from the GIANTT project 2004-2007].
Nederlands tijdschrift voor geneeskunde 2010;154():A775.
2009: Bruce Wolffenbuttel; L J Klaff; R Bhushan; J L Fahrbach; H Jiang; S Martin
Initiating insulin therapy in elderly patients with Type 2 diabetes: efficacy and safety of lispro mix 25 vs. basal insulin combined with oral glucose-lowering agents.
Diabetic medicine : a journal of the British Diabetic Association 2009;26(11):1147-55.
2009: Ilone C Hospers; Johan G van der Laan; Clark J Zeebregts; Patrick Nieboer; Bruce Wolffenbuttel; Rudi A Dierckx; Herman G Kreeftenberg; Pieter L Jager; Riemer H J A Slart
Vertebral fracture assessment in supine position: comparison by using conventional semiquantitative radiography and visual radiography.
Radiology 2009;251(3):822-8.
2009: John B Buse; Bruce Wolffenbuttel; William H Herman; Natalie K Shemonsky; Honghua H Jiang; Jessie L Fahrbach; Jamie L Scism-Bacon; Sherry A Martin
DURAbility of basal versus lispro mix 75/25 insulin efficacy (DURABLE) trial 24-week results: safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes.
Diabetes care 2009;32(6):1007-13.
2009: William H Herman; Kathleen M Dungan; Bruce Wolffenbuttel; John B Buse; Jessie L Fahrbach; Honghua Jiang; Sherry Martin
Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes.
The Journal of clinical endocrinology and metabolism 2009;94(5):1689-94.
2008: Bruce Wolffenbuttel; Gerrit van den Berg; Eelco W Hoving; M M van der Klauw
[The natural course of non-functioning pituitary adenomas].
Nederlands tijdschrift voor geneeskunde 2008;152(47):2537-43.
2008: H Alec Ross; P P C A Menheere; C M G Thomas; A H Mudde; M Kouwenberg; Bruce Wolffenbuttel
Interference from heterophilic antibodies in seven current TSH assays.
Annals of clinical biochemistry 2008;45(Pt 6):616.
2008: H R Bangma; G P A Smit; J B M Kuks; René G Grevink; Bruce Wolffenbuttel
[Two patients with mitochondrial respiratory chain disease].
Nederlands tijdschrift voor geneeskunde 2008;152(42):2298-301.
2008: Ha T T Phan; Pieter L Jager; John T M Plukker; Bruce Wolffenbuttel; Rudi A Dierckx; Thera P Links
Comparison of 11C-methionine PET and 18F-fluorodeoxyglucose PET in differentiated thyroid cancer.
Nuclear medicine communications 2008;29(8):711-6.
2008: A Caroline Heijckmann; Maya S P Huijberts; Erik J Schoon; Piet Geusens; Jolanda De Vries; Paul P C A Menheere; Eveline van der Veer; Bruce Wolffenbuttel; Reinhold W Stockbrugger; Bianca Dumitrescu; AC Nieuwenhuijzen Kruseman
High prevalence of morphometric vertebral deformities in patients with inflammatory bowel disease.
European journal of gastroenterology & hepatology 2008;20(8):740-7.
2008: A Caroline Heijckmann; Marjolein Drent; B Dumitrescu; Jolanda De Vries; AC Nieuwenhuijzen Kruseman; Bruce Wolffenbuttel; Piet Geusens; Maya S P Huijberts
Progressive vertebral deformities despite unchanged bone mineral density in patients with sarcoidosis: a 4-year follow-up study.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2008;19(6):839-47.
2008: Ha T T Phan; Pieter L Jager; Anne M J Paans; John T M Plukker; M G G Sturkenboom; Wim J Sluiter; Bruce Wolffenbuttel; Rudi A Dierckx; Thera P Links
The diagnostic value of 124I-PET in patients with differentiated thyroid cancer.
European journal of nuclear medicine and molecular imaging 2008;35(5):958-65.
2008: Wendy Koolhaas; A Prak; H M Stiekema; HG Kreeftenberg; Bruce Wolffenbuttel; Pieter L Jager
[Efficient and improved diagnosis of osteoporosis by simultaneous bone density measurement and spinal morphometry].
Nederlands tijdschrift voor geneeskunde 2008;152(16):938-43.
2008: Susanne H Meeuwisse-Pasterkamp; Melanie M van der Klauw; Bruce Wolffenbuttel
Type 2 diabetes mellitus: prevention of macrovascular complications.
Expert review of cardiovascular therapy 2008;6(3):323-41.
2008: Voorham Jaco; Flora M Haaijer-Ruskamp; Ronald P Stolk; Bruce Wolffenbuttel; Petra Denig
Influence of elevated cardiometabolic risk factor levels on treatment changes in type 2 diabetes.
Diabetes care 2008;31(3):501-3.
2008: Voorham Jaco; Petra Denig; Bruce Wolffenbuttel; Flora M Haaijer-Ruskamp
Cross-sectional versus sequential quality indicators of risk factor management in patients with type 2 diabetes.
Medical care 2008;46(2):133-41.
2008: R de Vries; A K Groen; F G Perton; Geesje M Dallinga-Thie; M J A van Wijland; Lambert D Dikkeschei; Bruce Wolffenbuttel; Arie Van Tol; R P F Dullaart
Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification.
Atherosclerosis 2008;196(2):733-41.
2008: Fernie J A Penning-van Beest; Bruce Wolffenbuttel; Ron Herings
Haemoglobin A1c goal attainment in relation to dose in patients with diabetes mellitus taking metformin: a nested, case-control study.
Clinical drug investigation 2008;28(8):487-93.
2008: A Caroline Heijckmann; Bianca Dumitrescu; AC Nieuwenhuijzen Kruseman; Piet Geusens; Bruce Wolffenbuttel; Jolanda De Vries; Marjolein Drent; Maya S P Huijberts
Quantitative ultrasound does not identify patients with an inflammatory disease at risk of vertebral deformities.
BMC musculoskeletal disorders 2008;9():72.
2008: Susanna E Borggreve; Rindert de Vries; Geesje M Dallinga-Thie; Bruce Wolffenbuttel; A K Groen; Arie Van Tol; R P F Dullaart
The ability of plasma to stimulate fibroblast cholesterol efflux is associated with the -629C-->A cholesteryl ester transfer protein promoter polymorphism: role of lecithin: cholesterol acyltransferase activity.
Biochimica et biophysica acta 2008;1781(1-2):10-5.
2008: Ha T T Phan; Pieter L Jager; Jacqueline E van der Wal; Wim J Sluiter; John T M Plukker; Rudi A Dierckx; Bruce Wolffenbuttel; Thera P Links
The follow-up of patients with differentiated thyroid cancer and undetectable thyroglobulin (Tg) and Tg antibodies during ablation.
European journal of endocrinology / European Federation of Endocrine Societies 2008;158(1):77-83.
2008: Ronald P Stolk; judith rosmalen; Dirkje S Postma; Rudolf A de Boer; gerjan navis; Joris P J Slaets; Johan Ormel; Bruce Wolffenbuttel
Universal risk factors for multifactorial diseases: LifeLines: a three-generation population-based study.
European journal of epidemiology 2008;23(1):67-74.
2007: M B Bos; J H M de Vries; Bruce Wolffenbuttel; H Verhagen; J L Hillege; Edith J M Feskens
[The prevalence of the metabolic syndrome in the Netherlands: increased risk of cardiovascular diseases and diabetes mellitus type 2 in one quarter of persons under 60].
Nederlands tijdschrift voor geneeskunde 2007;151(43):2382-8.
2007: Bruce Wolffenbuttel
[Doubts as to the cardiovascular safety of rosiglitazone].
Nederlands tijdschrift voor geneeskunde 2007;151(40):2236-7; author reply 2237.
2007: J R Meinardi; Bruce Wolffenbuttel; R P F Dullaart
Cyclic Cushing's syndrome: a clinical challenge.
European journal of endocrinology / European Federation of Endocrine Societies 2007;157(3):245-54.
2007: J W B de Groot; Thera P Links; Willem J Sluiter; Bruce Wolffenbuttel; Theo Wiggers; John T M Plukker
Locoregional control in patients with palpable medullary thyroid cancer: results of standardized compartment-oriented surgery.
Head & neck 2007;29(9):857-63.
2007: Ha T T Phan; Pieter L Jager; John T M Plukker; Bruce Wolffenbuttel; Rudi A Dierckx; Thera P Links
Detection of bone metastases in thyroid cancer patients: bone scintigraphy or 18F-FDG PET?
Nuclear medicine communications 2007;28(8):597-602.
2007: André P van Beek; Alfons C M van den Bergh; Linda M van den Berg; Gerrit van den Berg; Joost C Keers; Johannes A Langendijk; Bruce Wolffenbuttel
Radiotherapy is not associated with reduced quality of life and cognitive function in patients treated for nonfunctioning pituitary adenoma.
International journal of radiation oncology, biology, physics 2007;68(4):986-91.
2007: Henk J G Bilo; S J J Logtenberg; Lambert D Dikkeschei; Nanne Kleefstra; Bruce Wolffenbuttel
[Assessment of renal function according to the NHG protocol 'Diabetes mellitus type 2': risk of overestimating the number of diabetes patients with renal dysfunction].
Nederlands tijdschrift voor geneeskunde 2007;151(18):1024-8.
2007: Henk J G Bilo; S J J Logtenberg; W J C de Grauw; Nanne Kleefstra; Bruce Wolffenbuttel
Time to move from serum creatinine to eGFR.
Diabetic medicine : a journal of the British Diabetic Association 2007;24(5):571-2; author reply 572-3.
2007: A Titia Lely; Jan Krikken; Stephan J L Bakker; Frans Boomsma; R P F Dullaart; Bruce Wolffenbuttel; gerjan navis
Low dietary sodium and exogenous angiotensin II infusion decrease plasma adiponectin concentrations in healthy men.
The Journal of clinical endocrinology and metabolism 2007;92(5):1821-6.
2007: Susanna E Borggreve; Hans L Hillege; Geesje M Dallinga-Thie; Paul E de Jong; Bruce Wolffenbuttel; Diederick Grobbee; Arie Van Tol; R P F Dullaart
High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides.
European heart journal 2007;28(8):1012-8.
2007: Gloria Alvarez Llamas; Ewa Szalowska; Marcel P de Vries; Desiree Weening; Karloes Landman; Annemieke Hoek; Bruce Wolffenbuttel; Han Roelofsen; roel vonk
Characterization of the human visceral adipose tissue secretome.
Molecular & cellular proteomics : MCP 2007;6(4):589-600.
2007: A Caroline Heijckmann; Maya S P Huijberts; Jolanda De Vries; Paul P C A Menheere; Eveline van der Veer; Arie C Nieuwenhuijzen Kruseman; Bruce Wolffenbuttel; Piet Geusens; Marjolein Drent
Bone turnover and hip bone mineral density in patients with sarcoidosis.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG / World Association of Sarcoidosis and Other Granulomatous Disorders 2007;24(1):51-8.
2007: Alfons C M van den Bergh; Gerrit van den Berg; Michiel A Schoorl; Wim J Sluiter; Anton M van der Vliet; Eelco W Hoving; Ben G Szabó; Johannes A Langendijk; Bruce Wolffenbuttel; R P F Dullaart
Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma: beneficial effect on local control without additional negative impact on pituitary function and life expectancy.
International journal of radiation oncology, biology, physics 2007;67(3):863-9.
2007: R P F Dullaart; G M Dallinga-Thie; Bruce Wolffenbuttel; Arie Van Tol
CETP inhibition in cardiovascular risk management: a critical appraisal.
European journal of clinical investigation 2007;37(2):90-8.
2007: Annemieke Roos; Stephan J L Bakker; Thera P Links; Rijk O B Gans; Bruce Wolffenbuttel
Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects.
The Journal of clinical endocrinology and metabolism 2007;92(2):491-6.
2007: Adrienne C M Persoon; Pieter L Jager; Wim J Sluiter; John T M Plukker; Bruce Wolffenbuttel; Thera P Links
A sensitive Tg assay or rhTSH stimulated Tg: what's the best in the long-term follow-up of patients with differentiated thyroid carcinoma?
PloS one 2007;2(8):e816.
2006: J W B de Groot; John T M Plukker; Bruce Wolffenbuttel; Theo Wiggers; Willem J Sluiter; Thera P Links
Determinants of life expectancy in medullary thyroid cancer: age does not matter.
Clinical endocrinology 2006;65(6):729-36.
2006: J W B de Groot; Ido P Kema; Henk Breukelman; Eveline van der Veer; Theo Wiggers; John T M Plukker; Bruce Wolffenbuttel; Thera P Links
Biochemical markers in the follow-up of medullary thyroid cancer.
Thyroid : official journal of the American Thyroid Association 2006;16(11):1163-70.
2006: Anouk N A van der Horst-Schrivers; Michiel N Kerstens; Bruce Wolffenbuttel
Preoperative pharmacological management of phaeochromocytoma.
The Netherlands journal of medicine 2006;64(8):290-5.
2006: Susanna E Borggreve; Hans L Hillege; Bruce Wolffenbuttel; Paul E de Jong; Mike W Zuurman; Gerrit van der Steege; Arie Van Tol; R P F Dullaart
An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study.
The Journal of clinical endocrinology and metabolism 2006;91(9):3382-8.
2006: Jasper W L Hartog; Aiko P J de Vries; Stephan J L Bakker; Reindert Graaff; Willem J Van Son; Jaap J Homan van der Heide; Rijk O B Gans; Bruce Wolffenbuttel; Paul E de Jong; Andries J Smit
Risk factors for chronic transplant dysfunction and cardiovascular disease are related to accumulation of advanced glycation end-products in renal transplant recipients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(8):2263-9.
2006: Adrienne C M Persoon; Thera P Links; Jürgen Wilde; Wim J Sluiter; Bruce Wolffenbuttel; Johannes M W van den Ouweland
Thyroglobulin (Tg) recovery testing with quantitative Tg antibody measurement for determining interference in serum Tg assays in differentiated thyroid carcinoma.
Clinical chemistry 2006;52(6):1196-9.
2006: R R H Nap; J R Meinardi; Gerrit van den Berg; R P F Dullaart; jakob de vries; Bruce Wolffenbuttel
[Long-term follow-up is indicated after surgery for a phaeochromocytoma].
Nederlands tijdschrift voor geneeskunde 2006;150(19):1045-9.
2006: Adrienne C M Persoon; Johannes M W van den Ouweland; Jürgen Wilde; Ido P Kema; Bruce Wolffenbuttel; Thera P Links
Clinical utility of an automated immunochemiluminometric thyroglobulin assay in differentiated thyroid carcinoma.
Clinical chemistry 2006;52(4):686-91.
2006: Rindert de Vries; Geesje M Dallinga-Thie; A J Smit; Bruce Wolffenbuttel; Arie Van Tol; R P F Dullaart
Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus.
Diabetologia 2006;49(2):398-404.
2006: J R Meinardi; Gerrit van den Berg; Bruce Wolffenbuttel; Ido P Kema; R P F Dullaart
Cyclical Cushing's syndrome due to an atypical thymic carcinoid.
The Netherlands journal of medicine 2006;64(1):23-7.
2006: Cyriel J A L Mentink; Bente K Kilhovd; G J W M Rondas-Colbers; Peter A Torjesen; Bruce Wolffenbuttel
Time course of specific AGEs during optimised glycaemic control in type 2 diabetes.
The Netherlands journal of medicine 2006;64(1):10-6.
2006: Joost C Keers; Jelte Bouma; Thera P Links; Jan C ter Maaten; Rijk O B Gans; Bruce Wolffenbuttel; Robbert Sanderman
One-year follow-up effects of diabetes rehabilitation for patients with prolonged self-management difficulties.
Patient education and counseling 2006;60(1):16-23.
2005: Rindert de Vries; Frank G Perton; Geesje M Dallinga-Thie; Arie M Van Roon; Bruce Wolffenbuttel; Arie Van Tol; R P F Dullaart
Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglycerides.
Diabetes 2005;54(12):3554-9.
2005: Jacqueline G Dolfing; Bruce Wolffenbuttel; Nienke M ten Hoor-Aukema; Dave H Schweitzer
Daily high doses of fluoxetine for weight loss and improvement in lifestyle before bariatric surgery.
Obesity surgery 2005;15(8):1185-91.
2005: Jacqueline G Dolfing; E F L Dubois; Bruce Wolffenbuttel; Nienke M ten Hoor-Aukema; Dave H Schweitzer
Different cycle ergometer outcomes in severely obese men and women without documented cardiopulmonary morbidities before bariatric surgery.
Chest 2005;128(1):256-62.
2005: Klaas P Koopmans; Adrienne H Brouwers; Marjolijn N De Hooge; Anouk N A van der Horst-Schrivers; Ido P Kema; Bruce Wolffenbuttel; Elisabeth G De Vries; Pieter L Jager
Carcinoid crisis after injection of 6-18F-fluorodihydroxyphenylalanine in a patient with metastatic carcinoid.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46(7):1240-3.
2005: A Caroline Heijckmann; Maya S P Huijberts; Piet Geusens; Jolanda De Vries; Paul P C A Menheere; Bruce Wolffenbuttel
Hip bone mineral density, bone turnover and risk of fracture in patients on long-term suppressive L-thyroxine therapy for differentiated thyroid carcinoma.
European journal of endocrinology / European Federation of Endocrine Societies 2005;153(1):23-9.
2005: Susanna E Borggreve; Hans L Hillege; Bruce Wolffenbuttel; Paul E de Jong; Stephan J L Bakker; Gerrit van der Steege; Arie Van Tol; R P F Dullaart
The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides.
The Journal of clinical endocrinology and metabolism 2005;90(7):4198-204.
2005: Bruce Wolffenbuttel; A A M Franken; H H Vincent
Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes -- CORALL study.
Journal of internal medicine 2005;257(6):531-9.
2005: Janine Nuver; Andries J Smit; Bruce Wolffenbuttel; Wim J Sluiter; Harald J Hoekstra; Dirk T Sleijfer; Jourik A Gietema
The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3718-25.
2005: R S M E Wouters; J M W van den Ouweland; J G J Pouwels; Bruce Wolffenbuttel
[Missed hyperinsulinaemia in a patient with an insulinoma].
Nederlands tijdschrift voor geneeskunde 2005;149(17):944-6.
2005: Michiel N Kerstens; Bruce Wolffenbuttel; R P F Dullaart
[Tissue-specific changes in cortisol metabolism and their potential role in the metabolic syndrome].
Nederlands tijdschrift voor geneeskunde 2005;149(16):871-6.
2005: R P F Dullaart; S C Riemens; J R Meinardi; Bruce Wolffenbuttel; Wim J Sluiter
Plasma adiponectin is modestly decreased during 24-hour insulin infusion but not after inhibition of lipolysis by Acipimox.
Scandinavian journal of clinical and laboratory investigation 2005;65(6):523-31.
2005: Rindert de Vries; Bruce Wolffenbuttel; Wim J Sluiter; Arie Van Tol; R P F Dullaart
Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects.
Clinical laboratory 2005;51(7-8):403-9.
2005: Isao Kuribayashi; Satoshi Nomoto; Guy Massa; Wilma Oostdijk; Jan M Wit; Bruce Wolffenbuttel; Yutaka Shizuta; Koichi Honke
Steroid 11-beta-hydroxylase deficiency caused by compound heterozygosity for a novel mutation, p.G314R, in one CYP11B1 allele, and a chimeric CYP11B2/CYP11B1 in the other allele.
Hormone research 2005;63(6):284-93.
2004: Joost C Keers; Thera P Links; Jelte Bouma; Rijk O B Gans; Jan C ter Maaten; Bruce Wolffenbuttel; Wim J Sluiter; Robbert Sanderman
Do diabetologists recognise self-management problems in their patients?
Diabetes research and clinical practice 2004;66(2):157-61.
2004: Nico C van de Merbel; Cyriel J A L Mentink; Gert Hendriks; Bruce Wolffenbuttel
Liquid chromatographic method for the quantitative determination of Nepsilon-carboxymethyllysine in human plasma proteins.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2004;808(2):163-8.
2004: Simon R Heller; S Colagiuri; S Vaaler; Bruce Wolffenbuttel; K Koelendorf; H H Friberg; K Windfeld; A Lindholm
Hypoglycaemia with insulin aspart: a double-blind, randomised, crossover trial in subjects with Type 1 diabetes.
Diabetic medicine : a journal of the British Diabetic Association 2004;21(7):769-75.
2004: Jasper W L Hartog; Andries J Smit; Willem J Van Son; gerjan navis; Rijk O B Gans; Bruce Wolffenbuttel; Paul E de Jong
Advanced glycation end products in kidney transplant patients: a putative role in the development of chronic renal transplant dysfunction.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;43(6):966-75.
2004: Fred Hartgens; G J W M Rietjens; Hans A Keizer; Harm Kuipers; Bruce Wolffenbuttel
Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).
British journal of sports medicine 2004;38(3):253-9.
2004: R J Rennenberg; B Bravenboer; Bruce Wolffenbuttel
[Empty sella syndrome as the cause of panhypopituitarism].
Nederlands tijdschrift voor geneeskunde 2004;148(1):33-6.
2004: Carel F Schaars; Petra Denig; Willeke N Kasje; Roy E Stewart; Bruce Wolffenbuttel; Flora M Haaijer-Ruskamp
Physician, organizational, and patient factors associated with suboptimal blood pressure management in type 2 diabetic patients in primary care.
Diabetes care 2004;27(1):123-8.
2003: Irmgard M J G Eijkelberg; Cor Spreeuwenberg; Bruce Wolffenbuttel; Loek J G P van Wilderen; Ingrid M Mur-Veeman
Nurse-led shared care diabetes projects: lessons from the nurses' viewpoint.
Health policy (Amsterdam, Netherlands) 2003;66(1):11-27.
2003: Paul A De Clercq; Arie Hasman; Bruce Wolffenbuttel
A consumer health record for supporting the patient-centered management of chronic diseases.
Medical informatics and the Internet in medicine 2003;28(2):117-27.
2003: Eric van Breda; Hans A Keizer; Harm Kuipers; Bruce Wolffenbuttel
Androgenic anabolic steroid use and severe hypothalamic-pituitary dysfunction: a case study.
International journal of sports medicine 2003;24(3):195-6.
2003: Bruce Wolffenbuttel; M M van der Klauw
[Psychiatric side effects associated with diphosphonate treatment].
Nederlands tijdschrift voor geneeskunde 2003;147(1):35-7.
2003: Paul B Leurs; René Van Oerle; Karly Hamulyak; Bruce Wolffenbuttel
Tissue factor pathway inhibitor (TFPI) release after heparin stimulation is increased in Type 1 diabetic patients with albuminuria.
Diabetic medicine : a journal of the British Diabetic Association 2003;20(1):16-22.
2002: A Caroline Heijckmann; J R Juttmann; Bruce Wolffenbuttel
Intravenous pamidronate compared with oral alendronate for the treatment of postmenopausal osteoporosis.
The Netherlands journal of medicine 2002;60(8):315-9.
2002: Paul B Leurs; Ronald P Stolk; Karly Hamulyak; René Van Oerle; Diederick Grobbee; Bruce Wolffenbuttel
Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes.
Diabetes care 2002;25(8):1340-5.
2002: Cyriel J A L Mentink; Marc Hendriks; Anita A G Levels; Bruce Wolffenbuttel
Glucose-mediated cross-linking of collagen in rat tendon and skin.
Clinica chimica acta; international journal of clinical chemistry 2002;321(1-2):69-76.
2002: Bert Vrijhoef; Joseph P M Diederiks; Cor Spreeuwenberg; Bruce Wolffenbuttel; L J G P van Wilderen
The nurse specialist as main care-provider for patients with type 2 diabetes in a primary care setting: effects on patient outcomes.
International journal of nursing studies 2002;39(4):441-51.
2002: Bruce Wolffenbuttel
[Postprandial glucose peaks in the pathogenesis of cardiovascular disease in diabetes mellitus; implications for metabolic control].
Nederlands tijdschrift voor geneeskunde 2002;146(14):654-8.
2002: W Ken Redekop; Marc A Koopmanschap; G E H M Rutten; Bruce Wolffenbuttel; Ronald P Stolk; Louis Niessen
Resource consumption and costs in Dutch patients with type 2 diabetes mellitus. Results from 29 general practices.
Diabetic medicine : a journal of the British Diabetic Association 2002;19(3):246-53.
2002: W Ken Redekop; Marc A Koopmanschap; Ronald P Stolk; G E H M Rutten; Bruce Wolffenbuttel; Louis Niessen
Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes.
Diabetes care 2002;25(3):458-63.
2002: Johannes M M Boots; Elly M van Duijnhoven; Maarten H L Christiaans; Bruce Wolffenbuttel; Johannes P van Hooff
Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction.
Journal of the American Society of Nephrology : JASN 2002;13(1):221-7.
2002: Elly M van Duijnhoven; Maarten H L Christiaans; Johannes M M Boots; Fred H M Nieman; Bruce Wolffenbuttel; Johannes P van Hooff
Glucose metabolism in the first 3 years after renal transplantation in patients receiving tacrolimus versus cyclosporine-based immunosuppression.
Journal of the American Society of Nephrology : JASN 2002;13(1):213-20.
2001: C A Heijckmann; Paul P C A Menheere; Jean-Pierre J E Sels; E A M Beuls; Bruce Wolffenbuttel
Clinical experience with Sandostatin LAR in patients with acromegaly.
The Netherlands journal of medicine 2001;59(6):286-91.
2001: Bert Vrijhoef; Joseph P M Diederiks; Cor Spreeuwenberg; Bruce Wolffenbuttel
Substitution model with central role for nurse specialist is justified in the care for stable type 2 diabetic outpatients.
Journal of advanced nursing 2001;36(4):546-55.
2001: Bert Vrijhoef; Cor Spreeuwenberg; Irmgard M J G Eijkelberg; Bruce Wolffenbuttel; Godefridus G van Merode
Adoption of disease management model for diabetes in region of Maastricht.
BMJ (Clinical research ed.) 2001;323(7319):983-5.
2001: Salim Yusuf; H Gerstein; B Hoogwerf; Janice Pogue; Jackie Bosch; Bruce Wolffenbuttel; B Zinman
Ramipril and the development of diabetes.
JAMA : the journal of the American Medical Association 2001;286(15):1882-5.
2001: WA Oranje; Jean-Pierre J E Sels; G J W M Rondas-Colbers; P J Lemmens; Bruce Wolffenbuttel
Effect of atorvastatin on LDL oxidation and antioxidants in normocholesterolemic type 2 diabetic patients.
Clinica chimica acta; international journal of clinical chemistry 2001;311(2):91-4.
2001: Bruce Wolffenbuttel; L D Elving; J A Maassen; B Bravenboer; J B L Hoekstra
-to: Waldhäusl W (2001) Editorial: Finally we have arrived in a new millennium. Diabetologia 44: 1-2.
Diabetologia 2001;44(7):923.
2001: Bruce Wolffenbuttel; M S Huijberts
[Disorders of lipid metabolism in 3 patients with diabetes mellitus type 2].
Nederlands tijdschrift voor geneeskunde 2001;145(16):761-5.
2001: Ellen E Blaak; Bruce Wolffenbuttel; Wim H M Saris; Maurice Pelsers; Anton J M Wagenmakers
Weight reduction and the impaired plasma-derived free fatty acid oxidation in type 2 diabetic subjects.
The Journal of clinical endocrinology and metabolism 2001;86(4):1638-44.
2001: Bruce Wolffenbuttel; Jean-Pierre J E Sels; Maya S P Huijberts
Rosiglitazone.
Expert opinion on pharmacotherapy 2001;2(3):467-78.
2001: E M Duijnhoven; Johannes M M Boots; Maarten H L Christiaans; Bruce Wolffenbuttel; Johannes P van Hooff
Influence of tacrolimus on glucose metabolism before and after renal transplantation: a prospective study.
Journal of the American Society of Nephrology : JASN 2001;12(3):583-8.
2001: Irmgard M J G Eijkelberg; Cor Spreeuwenberg; Ingrid M Mur-Veeman; Bruce Wolffenbuttel
From shared care to disease management: key-influencing factors.
International journal of integrated care 2001;1():e17.
2001: Paul A De Clercq; Arie Hasman; Bruce Wolffenbuttel
Design of a consumer health record for supporting the patient-centered management of chronic diseases.
Studies in health technology and informatics 2001;84(Pt 2):1445-9.
2001: Barbara Kopff; Slawomir Mucha; Bruce Wolffenbuttel; Józef Drzewoski
Diabetic ketoacidosis in a patient with acromegaly.
Medical science monitor : international medical journal of experimental and clinical research 2001;7(1):142-7.
2000: Torsten Lauritzen; S Griffin; Knut Borch-Johnsen; N J Wareham; Bruce Wolffenbuttel; G Rutten
The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2000;24 Suppl 3():S6-11.
2000: Ellen E Blaak; Anton J M Wagenmakers; Jan F C Glatz; Bruce Wolffenbuttel; Gerrit J Kemerink; CJ Langenberg; Guido A K Heidendal; Wim H M Saris
Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle.
American journal of physiology. Endocrinology and metabolism 2000;279(1):E146-54.
2000: Jan M S van Maanen; Harma Albering; Theo M C M De Kok; Simone G J van Breda; Daniëlle M J Curfs; Ingrid T M Vermeer; Anton W Ambergen; Bruce Wolffenbuttel; Jos C S Kleinjans; H M Reeser
Does the risk of childhood diabetes mellitus require revision of the guideline values for nitrate in drinking water?
Environmental health perspectives 2000;108(5):457-61.
2000: Jean-Pierre J E Sels; R M Wouters; Rob Lamers; Bruce Wolffenbuttel
Pitfall of the accessory spleen.
The Netherlands journal of medicine 2000;56(4):153-8.
2000: Bruce Wolffenbuttel; R Gomis; S Squatrito; N P Jones; Rita Patwardhan
Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients.
Diabetic medicine : a journal of the British Diabetic Association 2000;17(1):40-7.
1999: M B Graal; Bruce Wolffenbuttel
The use of sulphonylureas in the elderly.
Drugs & aging 1999;15(6):471-81.
1999: WA Oranje; G J W M Rondas-Colbers; G N Swennen; H Jansen; Bruce Wolffenbuttel
Lack of effect on LDL oxidation and antioxidant status after improvement of metabolic control in type 2 diabetes.
Diabetes care 1999;22(12):2083-4.
1999: Jean-Pierre J E Sels; Maya S P Huijberts; Bruce Wolffenbuttel
Miglitol, a new alpha-glucosidase inhibitor.
Expert opinion on pharmacotherapy 1999;1(1):149-56.
1999: Bruce Wolffenbuttel
Repaglinide--a new compound for the treatment of patients with type 2 diabetes.
The Netherlands journal of medicine 1999;55(5):229-34.
1999: Jan M S van Maanen; Harma Albering; Simone G J van Breda; Daniëlle M J Curfs; Anton W Ambergen; Bruce Wolffenbuttel; J C Kleinjans; H M Reeser
Nitrate in drinking water and risk of childhood diabetes in The Netherlands.
Diabetes care 1999;22(10):1750.
1999: Ellen E Blaak; Gerrit J Kemerink; M-T W Pakbiers; Bruce Wolffenbuttel; Guido A K Heidendal; Wim H M Saris
Microdialysis assessment of local adipose tissue lipolysis during beta-adrenergic stimulation in upper-body-obese subjects with type II diabetes.
Clinical science (London, England : 1979) 1999;97(4):421-8.
1999: WA Oranje; Bruce Wolffenbuttel
Lipid peroxidation and atherosclerosis in type II diabetes.
The Journal of laboratory and clinical medicine 1999;134(1):19-32.
1999: Bruce Wolffenbuttel; R J Heine
[Glycemic regulation and management of essential hypertension in diabetics with type 2 diabetes mellitus; the 'United Kingdom prospective diabetes study' of diabetic complications].
Nederlands tijdschrift voor geneeskunde 1999;143(23):1197-201.
1999: FC Huvers; Peter W de Leeuw; Alphons J H M Houben; CH de Haan; K Hamulyak; H Schouten; Bruce Wolffenbuttel; Nicolaas C Schaper
Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions.
Diabetes 1999;48(6):1300-7.
1999: FR Crijns; Bruce Wolffenbuttel; Jo De Mey; Harry A J Struijker Boudier
Mechanical properties of mesenteric arteries in diabetic rats: consequences of outward remodeling.
The American journal of physiology 1999;276(5 Pt 2):H1672-7.
1999: Ellen E Blaak; Wim H M Saris; Bruce Wolffenbuttel
Substrate utilization and thermogenic responses to beta-adrenergic stimulation in obese subjects with NIDDM.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 1999;23(4):411-8.
1999: Bruce Wolffenbuttel; R Landgraf
A 1-year multicenter randomized double-blind comparison of repaglinide and glyburide for the treatment of type 2 diabetes. Dutch and German Repaglinide Study Group.
Diabetes care 1999;22(3):463-7.
1999: Wim Engels; Marc van Bilsen; Bruce Wolffenbuttel; Ger J van der Vusse; Jan F C Glatz
Cytochrome P450, peroxisome proliferation, and cytoplasmic fatty acid-binding protein content in liver, heart and kidney of the diabetic rat.
Molecular and cellular biochemistry 1999;192(1-2):53-61.
1999: Bruce Wolffenbuttel; Jean-Pierre J E Sels; G J W M Rondas-Colbers; Paul P C A Menheere
Prognostic factors for successful insulin therapy in subjects with type 2 diabetes.
The Netherlands journal of medicine 1999;54(2):63-9.
1998: Jean-Pierre J E Sels; H E Verdonk; Bruce Wolffenbuttel
Effects of acarbose (Glucobay) in persons with type 1 diabetes: a multicentre study.
Diabetes research and clinical practice 1998;41(2):139-45.
1998: WA Oranje; G J W M Rondas-Colbers; G N Swennen; Bruce Wolffenbuttel
Lipid peroxidation in type 2 diabetes: relationship with macrovascular disease?
The Netherlands journal of medicine 1998;53(2):61-8.
1998: M B Graal; Bruce Wolffenbuttel
Consequences of long-term hyperparathyroidism.
The Netherlands journal of medicine 1998;53(1):37-42.
1998: FR Crijns; Harry A J Struijker Boudier; Bruce Wolffenbuttel
Arteriolar reactivity in conscious diabetic rats: influence of aminoguanidine treatment.
Diabetes 1998;47(6):918-23.
1998: Bruce Wolffenbuttel; Chantal M Boulanger; FR Crijns; Maya S P Huijberts; P Poitevin; G N Swennen; S Vasan; J J Egan; PC Ulrich; Anthony Cerami; Bernard I Lévy
Breakers of advanced glycation end products restore large artery properties in experimental diabetes.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(8):4630-4.
1998: Bruce Wolffenbuttel; G Mahla; D Muller; A Pentrup; D M Black
Efficacy and safety of a new cholesterol synthesis inhibitor, atorvastatin, in comparison with simvastatin and pravastatin, in subjects with hypercholesterolemia.
The Netherlands journal of medicine 1998;52(4):131-7.
1998: Bruce Wolffenbuttel; K Kitz; E M Beuls
Beneficial gamma-knife radiosurgery in a patient with Nelson's syndrome.
Clinical neurology and neurosurgery 1998;100(1):60-3.
1998: Bruce Wolffenbuttel; R J Heine
[Short-acting insulin analogs].
Nederlands tijdschrift voor geneeskunde 1998;142(8):397-400.
1997: CH de Haan; Francois M H van Dielen; Alphons J H M Houben; Peter W de Leeuw; FC Huvers; Jo De Mey; Bruce Wolffenbuttel; Nicolaas C Schaper
Peripheral blood flow and noradrenaline responsiveness: the effect of physiological hyperinsulinemia.
Cardiovascular research 1997;34(1):192-8.
1997: R K Gonera; WA Oranje; Bruce Wolffenbuttel
Shock of unknown origin--think of mastocytosis!
The Netherlands journal of medicine 1997;50(4):165-9.
1997: Paul B Leurs; René Van Oerle; Bruce Wolffenbuttel; Karly Hamulyak
Increased tissue factor pathway inhibitor (TFPI) and coagulation in patients with insulin-dependent diabetes mellitus.
Thrombosis and haemostasis 1997;77(3):472-6.
1996: Bruce Wolffenbuttel; Jean-Pierre J E Sels; G J W M Rondas-Colbers; Paul P C A Menheere; A C Nieuwenhuijzen Kruseman
Comparison of different insulin regimens in elderly patients with NIDDM.
Diabetes care 1996;19(12):1326-32.
1996: Tjerk W A de Bruin; Bruce Wolffenbuttel; J J Bonnier; J A Gevers Leuven; N Hoogerbrugge
[Additions to the consensus policy in the diagnosis and treatment of hyperlipidemia in clinical practice].
Nederlands tijdschrift voor geneeskunde 1996;140(45):2227-30.
1996: Bruce Wolffenbuttel; M B Graal
New treatments for patients with type 2 diabetes mellitus.
Postgraduate medical journal 1996;72(853):657-62.
1996: Jean-Pierre J E Sels; J J Nauta; Paul P C A Menheere; Bruce Wolffenbuttel; A C Nieuwenhuijzen Kruseman
Miglitol (Bay m 1099) has no extraintestinal effects on glucose control in healthy volunteers.
British journal of clinical pharmacology 1996;42(4):503-6.
1996: M Treskes; Bruce Wolffenbuttel
[Long-term complications in diabetes mellitus: role of irreversible glycosylation products].
Nederlands tijdschrift voor geneeskunde 1996;140(25):1299-303.
1996: Bruce Wolffenbuttel; D Giordano; HW Founds; Richard Bucala
Long-term assessment of glucose control by haemoglobin-AGE measurement.
Lancet 1996;347(9000):513-5.
1995: Bruce Wolffenbuttel; T W van Haeften
Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).
Drugs 1995;50(2):263-88.
1995: W J Mulder; A T Lavrijssen; Bruce Wolffenbuttel; J F Fiolet
[Treatment of hypercholesterolemia in the elderly].
Nederlands tijdschrift voor geneeskunde 1995;139(16):821-5.
1995: P B Leurs; René Van Oerle; Karly Hamulyak; Bruce Wolffenbuttel
Tissue factor pathway inhibitor activity in patients with IDDM.
Diabetes 1995;44(1):80-4.
1994: A C Kruseman; Jean-Pierre J E Sels; Bruce Wolffenbuttel
Alpha-glucosidase inhibitors in diabetes. Introduction.
European journal of clinical investigation 1994;24 Suppl 3():1.
1994: Jean-Pierre J E Sels; P J Kingma; Bruce Wolffenbuttel; Paul P C A Menheere; J H Branolte; A C Nieuwenhuijzen Kruseman
Effect of miglitol (BAY m-1099) on fasting blood glucose in type 2 diabetes mellitus.
The Netherlands journal of medicine 1994;44(6):198-201.
1994: Maya S P Huijberts; Bruce Wolffenbuttel; F R Crijns; A C Nieuwenhuijzen Kruseman; M H Bemelmans; Harry A J Struijker Boudier
Aminoguanidine reduces regional albumin clearance but not urinary albumin excretion in streptozotocin-diabetic rats.
Diabetologia 1994;37(1):10-4.
1993: Bruce Wolffenbuttel; C H Drossaert; A P Visser
Determinants of injecting insulin in elderly patients with type II diabetes mellitus.
Patient education and counseling 1993;22(3):117-25.
1993: Bruce Wolffenbuttel
The DCCT: "metabolic control matters". Diabetes Control and Complications Trial.
The Netherlands journal of medicine 1993;43(5-6):241-5.
1993: K Hasan; B J Heesen; John A Corbett; Michael L McDaniel; K Chang; W Allison; Bruce Wolffenbuttel; Joseph R Williamson; Ronald G Tilton
Inhibition of nitric oxide formation by guanidines.
European journal of pharmacology 1993;249(1):101-6.
1993: Bruce Wolffenbuttel; Maya S P Huijberts; B J Heesen; P B Leurs; A C Nieuwenhuijzen Kruseman
[Adequate adjustment of diabetes mellitus decreases the possibility of diabetic complications].
Nederlands tijdschrift voor geneeskunde 1993;137(43):2179-83.
1993: Bruce Wolffenbuttel
Type 2 diabetes mellitus. Aspects of complications and treatment.
The Netherlands journal of medicine 1993;43(3-4):187-99.
1993: Maya S P Huijberts; Bruce Wolffenbuttel; H A Boudier; F R Crijns; A C Kruseman; P Poitevin; Bernard I Lévy
Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats.
The Journal of clinical investigation 1993;92(3):1407-11.
1993: B J Heesen; Bruce Wolffenbuttel; P B Leurs; Jean-Pierre J E Sels; Paul P C A Menheere; S E Jäckle-Beckers; A C Nieuwenhuijzen Kruseman
Lipoprotein(a) levels in relation to diabetic complications in patients with non-insulin-dependent diabetes.
European journal of clinical investigation 1993;23(9):580-4.
1993: Maya S P Huijberts; Bruce Wolffenbuttel; F Crijns; A N Kruseman; M Bemelmans; H Van Essen; J Smits; H S Boudier
Inhibition of angiotensin-converting enzyme reduces urinary albumin excretion but not regional albumin clearance in experimental diabetes.
European journal of pharmacology 1993;240(2-3):207-12.
1993: Bruce Wolffenbuttel; Maya S P Huijberts
Aminoguanidine, a potential drug for the treatment of diabetic complications.
The Netherlands journal of medicine 1993;42(5-6):205-8.
1993: Bruce Wolffenbuttel; P B Leurs; Jean-Pierre J E Sels; G J W M Rondas-Colbers; Paul P C A Menheere; A C Nieuwenhuijzen Kruseman
Improved blood glucose control by insulin therapy in type 2 diabetic patients has no effect on lipoprotein(a) levels.
Diabetic medicine : a journal of the British Diabetic Association 1993;10(5):427-30.
1993: WA Oranje; Bruce Wolffenbuttel
Low cholesterol and excess mortality: a real relationship?
The Netherlands journal of medicine 1993;42(3-4):89-91.
1993: Bruce Wolffenbuttel; T W Van Haeften
Non-insulin dependent diabetes mellitus: defects in insulin secretion.
European journal of clinical investigation 1993;23(2):69-79.
1993: Bruce Wolffenbuttel; L Nijst; Jean-Pierre J E Sels; Paul P C A Menheere; P G Müller; A C Kruseman
Effects of a new oral hypoglycaemic agent, repaglinide, on metabolic control in sulphonylurea-treated patients with NIDDM.
European journal of clinical pharmacology 1993;45(2):113-6.
1992: Bruce Wolffenbuttel; Jean-Pierre J E Sels; B J Heesen; Paul P C A Menheere; A C Kruseman
Lipoprotein(A) levels and diabetes control.
Diabetes care 1992;15(7):941.
1992: Bruce Wolffenbuttel; Paul P C A Menheere; L Nijst; G J W M Rondas-Colbers; Jean-Pierre J E Sels; A C Nieuwenhuijzen Kruseman
Glucagon-stimulated insulin secretion in patients with type 2 diabetes mellitus: support for the concept of glucose toxicity.
The Netherlands journal of medicine 1992;40(5-6):277-82.
1992: Bruce Wolffenbuttel; Jean-Pierre J E Sels; B J Heesen; Paul P C A Menheere; A C Nieuwenhuijzen Kruseman
[Effects of dietary fiber and insulin treatment on serum levels of lipids and lipoprotein (a) in patients with type II diabetes mellitus].
Nederlands tijdschrift voor geneeskunde 1992;136(15):739-42.
1992: H G Peltenburg; Bruce Wolffenbuttel; M H Booster; Paul P C A Menheere; Karel M L Leunissen; Gauke Kootstra; Johannes P van Hooff
Reperfusion injury of pancreas allografts: relation to islet cell function.
Transplant international : official journal of the European Society for Organ Transplantation 1992;5 Suppl 1():S270-1.
1992: H G Peltenburg; Anton T M G Tiebosch; P M van den Berg-Loonen; E van Ballegooie; Karel M L Leunissen; Bruce Wolffenbuttel; R Wijnen; Gauke Kootstra; Johannes P van Hooff
A positive T cell crossmatch and accelerated acute rejection of a pancreas-spleen allograft.
Transplantation 1992;53(1):226-8.
1991: Bruce Wolffenbuttel; Jean-Pierre J E Sels; S Verhoeven; A C Nieuwenhuijzen Kruseman
[Regulation of diabetes and late complications in the ambulatory treatment of patients with Type II diabetes mellitus].
Nederlands tijdschrift voor geneeskunde 1991;135(50):2387-91.
1991: Bruce Wolffenbuttel; S van Vliet; A J Knols; W L Slits; Jean-Pierre J E Sels; A C Nieuwenhuijzen Kruseman
Clinical characteristics and management of diabetic patients residing in a nursing home.
Diabetes research and clinical practice 1991;13(3):199-206.
1991: Bruce Wolffenbuttel; G J W M Rondas-Colbers; Paul P C A Menheere; Jean-Pierre J E Sels; A C Nieuwenhuijzen Kruseman
[The effects of insulin combined with glibenclamide on glucose and lipid metabolism in patients with Type II diabetes mellitus].
Nederlands tijdschrift voor geneeskunde 1991;135(24):1080-4.
1991: Jean-Pierre J E Sels; T J Postmes; Bruce Wolffenbuttel; A C Nieuwenhuijzen Kruseman
Dietary fibre in the management of diabetes mellitus: a review.
The Netherlands journal of medicine 1991;38(5-6):265-77.
1990: R T van Deursen; A C Nieuwenhuijzen Kruseman; C P Degenaar; Bruce Wolffenbuttel
[The effects of the cholesterol synthesis inhibitor simvastatin in patients with hypercholesterolemia with and without diabetes mellitus].
Nederlands tijdschrift voor geneeskunde 1990;134(44):2142-6.
1990: Bruce Wolffenbuttel; B M van Ouwerkerk; B F Veldhuyzen; P H Geelhoed-Duijvestijn; G Jakobsen; L G van Doorn
Comparative effects of two different multiple injection regimens on blood glucose control and patient acceptance in type 1 diabetes.
Diabetic medicine : a journal of the British Diabetic Association 1990;7(8):695-9.
1990: P J Kingma; J P Simons; A C Nieuwenhuijzen Kruseman; Bruce Wolffenbuttel
Calcium entry blockers and their effects on glucose metabolism.
The Netherlands journal of medicine 1990;36(1-2):32-8.
1990: Bruce Wolffenbuttel; R F A Weber; L Weeks; P M van Koetsveld; L Verschoor
Twice daily insulin therapy in patients with type 2 diabetes and secondary failure to sulphonylureas.
Diabetes research (Edinburgh, Scotland) 1990;13(2):79-84.
1989: Bruce Wolffenbuttel; R F A Weber; P M van Koetsveld; L Weeks; L Verschoor
A randomized crossover study of sulphonylurea and insulin treatment in patients with type 2 diabetes poorly controlled on dietary therapy.
Diabetic medicine : a journal of the British Diabetic Association 1989;6(6):520-5.
1989: A C Nieuwenhuijzen Kruseman; C P Degenaar; Bruce Wolffenbuttel
[The value of Micro-Bumin test reagent tablets for the detection of micro-albuminuria in patients with diabetes mellitus].
Nederlands tijdschrift voor geneeskunde 1989;133(1):40-1.
1989: Bruce Wolffenbuttel; R F A Weber; P M Van Koetsveld; L Verschoor
Limitations of diet therapy in patients with non-insulin-dependent diabetes mellitus.
International journal of obesity 1989;13(2):173-82.
1988: Bruce Wolffenbuttel; J Vreeburg
Insulin therapy does not diminish beta-cell damage in the neonatal streptozotocin-injected rat.
Diabetes research (Edinburgh, Scotland) 1988;9(2):77-9.
1988: J N Groen; Bruce Wolffenbuttel; M G Baggen; R A Stallaert; M E Prins; J C Birkenhäger
Tuberculosis of the thyroid gland.
The Netherlands journal of medicine 1988;32(3-4):199-203.
1987: Bruce Wolffenbuttel; R F Weber; M E Prins; L Verschoor
Premature ovarian failure and autoimmune hypothyroidism in the absence of Addison's disease.
The Netherlands journal of medicine 1987;30(3-4):128-34.
1986: Bruce Wolffenbuttel; Albert W van Toorenenbergen; Bert G Blijenberg; L Verschoor; R F A Weber
[Determination of the urinary albumin excretion in the early case-finding of nephropathy in patients with diabetes mellitus].
Nederlands tijdschrift voor geneeskunde 1986;130(44):1995-8.
1986: L Verschoor; Bruce Wolffenbuttel; R F Weber
Beta-blockade and carbohydrate metabolism: theoretical aspects and clinical implications.
Journal of cardiovascular pharmacology 1986;8 Suppl 11():S92-5.
1985: Bruce Wolffenbuttel; R F Weber; G S Kho
Pyopneumothorax: a rare complication of Wegener's granulomatosis.
European journal of respiratory diseases 1985;67(3):223-7.
1983: Bruce Wolffenbuttel; P D Verdouw
Nifedipine and myocardial performance in the presence and absence of beta-blockade with propranolol.
Archives internationales de pharmacodynamie et de thérapie 1983;266(1):83-92.
1983: Bruce Wolffenbuttel; P D Verdouw; M G Scheffer; H P Bom; R E Bijleveld; P G Hugenholtz
Significance of haemodynamic variables in coronary care unit for prediction of survival after acute myocardial infarction.
British heart journal 1983;50(3):266-72.
1983: P D Verdouw; Bruce Wolffenbuttel; M G Scheffer
Cardiovascular actions of the calmodulin inhibitor felodipine.
Naunyn-Schmiedeberg's archives of pharmacology 1983;323(4):350-4.
1983: P D Verdouw; Bruce Wolffenbuttel
The effect of felodipine on ventricular fibrillation after coronary artery ligation in the anaesthetized pig.
British journal of pharmacology 1983;79(1):6-8.
1983: P D Verdouw; Bruce Wolffenbuttel; F J ten Cate
Nifedipine with and without propranolol in the treatment of myocardial ischemia: effect on ventricular arrhythmias and recovery of regional wall function.
European heart journal 1983;4 Suppl C():101-8.
1983: P D Verdouw; Bruce Wolffenbuttel; W J van der Giessen
Domestic pigs in the study of myocardial ischemia.
European heart journal 1983;4 Suppl C():61-7.
1981: Bruce Wolffenbuttel; P D Verdouw; P G Hugenholtz
Immediate and two year prognosis after acute myocardial infarction: prediction from non-invasive as well as invasive parameters in the same individuals.
European heart journal 1981;2(5):375-87.